DRMA Insider Trading Activity and SEC Form 4 Filings
DRMA insider trading summary
Over the past 12 months, insiders at Dermata Therapeutics, Inc. (DRMA) reported 1 open-market purchase worth $1K by 1 insider and 1 sale worth $13 by 1 insider on SEC Form 4. Net insider buying was $1K.
Latest DRMA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Kathleen D. Scott | Director | Sell | $13 (11 @ $1.19) |
| Feb 17, 2026 | Munera Maria E Bedoya-Toro | SVP, Regulatory Affairs | Buy | $1K (1,000 @ $1.27) |
| Nov 23, 2021 | Gerald T Proehl | President, CEO and Chairman | Buy | $48K (20,000 @ $2.40) |
| Aug 17, 2021 | David F Hale | Director | Buy | $0 (35,714 @ $0.00) |
| Aug 17, 2021 | Gerald T Proehl | President, CEO and Chairman | Buy | $0 (142,857 @ $0.00) |
| Aug 16, 2021 | Gerald T Proehl | President, CEO and Chairman | Buy | $50K (10,000 @ $4.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.